HC Wainwright Issues Pessimistic Outlook for BDTX Earnings
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Free Report) – Stock analysts at HC Wainwright dropped their Q1 2025 earnings per share (EPS) estimates for Black Diamond Therapeutics in a research report issued on Tuesday, March 18th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.32) for the […]
